Prevalence and clinical association with calcinosis cutis in early systemic sclerosis

References

• Avouac J, Mogavero G, Guerini H, Drapé J, Mathieu A, Kahan A, et al. Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis. 2011;70(4):630–3.
   PubMed Web of Science ®Google Scholar
• Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, et al. Radiological hand involvement in systemic sclerosis. Ann Rheum Dis. 2006;65(8):1088–92.
   PubMed Web of Science ®Google Scholar
• Khanna D. Diagnosis and treatment of systemic and localized scleroderma. Expert Rev Dermatol. 2011;6(3):287–302.
   Google Scholar
• Young A, Namas R, Dodge C, Khanna D. Hand impairment in systemic sclerosis: various manifestations and currently available treatment. Curr Treatm Opt Rheumatol. 2016;2(3):252–69.
   PubMedGoogle Scholar
• Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol. 2018;30(6):554–61.
   PubMed Web of Science ®Google Scholar
• Golovach IY. Calcinosis in systemic sclerosis: prevalence, clinical picture, management, complications. Pain Joints Spine. 2019;9(2):108–119.
   Google Scholar
• Valenzuela A, Chung L. Calcinosis: pathophysiology and management. Curr Opin Rheumatol. 2015;27(6):542–8.
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Baron M, Herrick AL, Proudman S, Stevens W, Rodriguez-Reyna TS, et al. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: a Scleroderma Clinical Trials Consortium study. Semin Arthritis Rheum. 2016;46(3):344–9.
   PubMed Web of Science ®Google Scholar
• Yang JH, Kim JW, Park HS, Jang SJ, Choi JC. Calcinosis cutis of the fingertip associated with Raynaud's phenomenon. J Dermatol. 2006;33(12):884–6.
   PubMed Web of Science ®Google Scholar
• Koutaissoff S, Vanthuyne M, Smith V, De Langhe E, Depresseux G, Westhovens R, et al. Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations. Semin Arthritis Rheum. 2011;40(5):455–60.
   PubMed Web of Science ®Google Scholar
• Van Den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–47.
   PubMed Web of Science ®Google Scholar
• LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger JT, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–5.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.
   PubMed Web of Science ®Google Scholar
• Savarino E, Furnari M, de Bortoli N, Martinucci I, Bodini G, Ghio M, et al. Gastrointestinal involvement in systemic sclerosis. Presse Med. 2014;43:e279–e91.
   PubMed Web of Science ®Google Scholar
• Chung L, Valenzuela A, Fiorentino D, Stevens K, Li S, Harris J, et al. Validation of a novel radiographic scoring system for calcinosis affecting the hands of patients with systemic sclerosis. Arthritis Care Res. 2015;67(3):425–30.
   Web of Science ®Google Scholar
• Gutierrez A Jr., Wetter DA. Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther. 2012;25(2):195–206.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Peansukwech U, Mahakkanukrauh A, Suwannaroj S, Pongkulkiat P, Khamphiw P, et al. Clinical characteristics and outcomes of 566 Thais with systemic sclerosis: a cohort study. Int J Rheum Dis. 2020;23(7):945–57.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Watcharenwong P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais. Int J Rheum Dis. 2017;20(10):1572–81.
   PubMed Web of Science ®Google Scholar
• Foocharoen C, Suwannachat P, Netwijitpan S, Mahakkanukrauh A, Suwannaroj S, Nanagara R, et al. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I. Int J Rheum Dis. 2016;19(3):312–20.
   PubMed Web of Science ®Google Scholar
• Pescatore LA, Gamarra LF, Liberman M. Multifaceted mechanisms of vascular calcification in aging. Arterioscler Thromb Vasc Biol. 2019;39(7):1307–16.
   PubMed Web of Science ®Google Scholar
• Wegiel J, Kuchna I, Wisniewski T, de Leon M, Reisberg B, Pirttila T, et al. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome. Acta Neuropathol. 2002;103(4):333–43.
   PubMed Web of Science ®Google Scholar
• Freire V, Moser TP, Lepage-Saucier M. Radiological identification and analysis of soft tissue musculoskeletal calcifications. Insights Imaging. 2018;9(4):477–92.
   PubMed Web of Science ®Google Scholar
• Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005;34(6):805–12.
   PubMed Web of Science ®Google Scholar
• McCarty DJ. Arthritis associated with crystals containing calcium. Med Clin North Am. 1986;70(2):437–54.
   PubMed Web of Science ®Google Scholar
• Carpentier PH, Satger B, Poensin D, Maricq HR. Incidence and natural history of Raynaud phenomenon: a long-term follow-up (14 years) of a random sample from the general population. J Vasc Surg. 2006;44(5):1023–8.
   PubMed Web of Science ®Google Scholar
• Nitsche A. Raynaud, digital ulcers and calcinosis in scleroderma. Reumatol Clin. 2012;8(5):270–7.
   PubMedGoogle Scholar
• Muangchan C, Harding S, Khimdas S, Bonner A, Baron M, Pope J. Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group. Arthritis Care Res. 2012;64(9):1405–14.
   PubMed Web of Science ®Google Scholar
• Mitev A, Christ L, Feldmann D, Binder M, Möller K, Kanne A-M, et al. Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide. Arthritis Res Ther. 2019;21(1):262.
   PubMed Web of Science ®Google Scholar